NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

Historical Holders from Q2 2021 to Q3 2025

Symbol
NPCE on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
25.9M
Holdings value
$268M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
80
Number of buys
42
Number of sells
-49
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Polar Capital Holdings Plc 9.13% $34.5M 2.97M Polar Capital Holdings Plc 31 Mar 2025
Soleus Private Equity Fund I, L.P. 8.9% $30.5M 2.96M Guy Levy 30 Sep 2025
ORBIMED ADVISORS LLC 8% -22.7% $26.7M -$8.1M 2.61M -23.3% OrbiMed Advisors LLC 30 Jun 2025
MORGAN STANLEY 8.3% $28.9M 2.49M Morgan Stanley 31 Dec 2024
Soleus Capital Master Fund, L.P. 7% $23.5M 2.3M Soleus Capital Management, L.P. 30 Jun 2025
Kent Lake PR LLC 4.9% -2% $17.2M $117K 1.48M +0.68% Kent Lake PR LLC 31 Dec 2024

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 25.9M $268M +$34.2M $10.31 80
2025 Q2 22.5M $251M -$19.7M $11.14 98
2025 Q1 23.9M $294M +$42.1M $12.29 89
2024 Q4 20.9M $234M +$8.99M $11.19 61
2024 Q3 14.8M $103M +$1.47M $6.97 48
2024 Q2 14.4M $109M +$4.46M $7.56 51
2024 Q1 13.4M $176M +$9.05M $13.20 53
2023 Q4 12.7M $131M +$2.44M $10.31 41
2023 Q3 18.1M $176M +$5.45M $9.73 24
2023 Q2 17.5M $78.6M -$756K $4.49 20
2023 Q1 17.7M $82M +$1.75M $4.64 24
2022 Q4 17.4M $25.9M -$2.68M $1.49 22
2022 Q3 18.2M $68.1M -$1.02M $3.75 27
2022 Q2 18.4M $91.2M -$26.3K $4.95 26
2022 Q1 18.2M $150M -$117K $8.21 37
2021 Q4 18M $182M +$1.95M $10.08 41
2021 Q3 11.2M $177M +$509K $15.85 39
2021 Q2 10.9M $259M +$259M $23.79 44